RXPA 380 is a potent and selective C-terminal domain angiotensin-converting enzyme (ACE) inhibitor, exhibiting high affinity with a Ki of 3 nM and an IC50 of 2.5 nM against human recombinant ACE mutants. This small molecule is a valuable research tool for investigating the distinct roles of ACE domains in cardiovascular physiology and in vitro enzymatic studies.
Molekulargewicht:
617.63
CAS Nummer:
[564479-79-4]
Formel:
C33H36N3O7P
Target-Kategorie:
Angiotensin-converting Enzyme (ACE),Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten